Spring
Spring Health is a mental health platform for employers, offering personalized care plans using machine-learning technology for various services.
Secondary Market Price
How Spring Measures Up
To help you manage your Spring equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series B
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Spring's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Spring Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Spring's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Spring Health provides a comprehensive mental health benefits platform for employers and health plans. The company's current services include a centralized access point for various types of care, such as therapy, coaching, medication management, and employee assistance program (EAP) services. It utilizes proprietary assessments and machine-learning technology to create personalized care plans for individuals, who are then paired with a Care Navigator to help with appointments and resources. Founded in 2016 by April Koh and Adam Chekroud, the New York-based company has since grown to between 1,001 and 5,000 employees and achieved a market valuation of $2 billion as of September 2021.
Looking forward, Spring Health plans to continue expanding its specialty care offerings and its integrated network of providers. Recent announcements indicate a focus on targeted support systems, including the launch of a Neurodiversity Hub that provides access to specialized therapists and resources in 51 languages. The company's in-house manager development program, GROVE, recently received a Gold award from the Brandon Hall Group, and the company plans to continue scaling this initiative. A Series E funding round in August 2024 raised $100 million, which will support the continued development of its platform and services.
- GreatPoint Ventures
- August Capital
- GM Ventures
- RRE Ventures
- Galaxy Digital
- Multicoin Capital
- The Pritzker Group
- CardWorks
- TransUnion
- Co-Founder, Adam Jiwan
- Co-Founder, John Sun
- Co-Founder, Anna Fridman
- Co-Founder, Daniel Mason
- Co-Founder, Paul Zhang
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Spring worth joining?
Deciding whether to join a startup like Spring involves evaluating its growth potential, company culture, and your personal career goals. To help assess the financial upside, platforms like Prospect can model the potential value of your equity compensation, giving you a clearer picture of the opportunity.
What should I do with my Spring stock?
Managing your Spring stock requires a personalized strategy based on your financial situation, risk tolerance, and the company's performance. Prospect offers customized option exercise and stock sale strategies to help you maximize your post-tax equity value and make informed decisions.
Can you sell Spring stock?
Selling stock in a private company like Spring is typically restricted and only possible during specific liquidity events, such as a tender offer or acquisition. Tools like those offered by Prospect can help you navigate these events by determining which shares are most tax-optimal to sell.
How can I find the value of my Spring stock?
The value of private company stock is not publicly available and is often determined by the most recent funding round's valuation, known as the 409A valuation. Prospect uses proprietary predictive models, trained on data used by top VCs, to help you forecast the future value of your shares.
What is Spring's equity worth?
The precise worth of your equity in a private company like Spring depends on the company's current valuation and the total number of shares outstanding. You can get a more data-driven estimate by using a platform like Prospect, which projects a likely range of outcomes for your startup equity.
What is Spring's stock ticker symbol?
As a private, pre-IPO company, Spring does not have a stock ticker symbol because its shares are not traded on a public stock exchange. Ticker symbols are only assigned to companies once they complete an Initial Public Offering (IPO) and are listed on an exchange like the NYSE or NASDAQ.
Can I buy or sell Spring stock?
Buying or selling stock in a private company like Spring is generally limited to employees, accredited investors, and specific liquidity events like secondary market sales or tender offers. If you are an employee considering a sale, Prospect provides tools to help you decide how much to sell and which shares are the most tax-efficient.
What is the criteria to buy or invest in Spring stock?
Investing in a private company like Spring is typically reserved for accredited investors who meet specific income or net worth requirements set by financial regulators. Employees receive equity as part of their compensation, but external investment opportunities are not generally available to the public before an IPO.
